Business Description
Teladoc Health Inc
NAICS : 621999
SIC : 8011
ISIN : BRT2DHBDR009
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.69 | |||||
Equity-to-Asset | 0.53 | |||||
Debt-to-Equity | 0.7 | |||||
Debt-to-EBITDA | 9.28 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -3.61 | |||||
Beneish M-Score | -3.15 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 9.4 | |||||
3-Year EPS without NRI Growth Rate | 36.2 | |||||
3-Year Book Growth Rate | -49.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | -29.03 | |||||
Future 3-5Y Total Revenue Growth Rate | 3.36 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 13.15 | |||||
9-Day RSI | 20.37 | |||||
14-Day RSI | 25.36 | |||||
6-1 Month Momentum % | -7.22 | |||||
12-1 Month Momentum % | -40.34 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.82 | |||||
Quick Ratio | 3.74 | |||||
Cash Ratio | 2.82 | |||||
Days Inventory | 16.95 | |||||
Days Sales Outstanding | 29.79 | |||||
Days Payable | 15.47 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.5 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 70.81 | |||||
Operating Margin % | -8.57 | |||||
Net Margin % | -8.9 | |||||
FCF Margin % | 7.57 | |||||
ROE % | -10.14 | |||||
ROA % | -5.38 | |||||
ROIC % | -7.17 | |||||
ROC (Joel Greenblatt) % | -302.39 | |||||
ROCE % | -5.27 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Price-to-Owner-Earnings | 34.24 | |||||
PS Ratio | 0.76 | |||||
PB Ratio | 0.88 | |||||
Price-to-Free-Cash-Flow | 9.88 | |||||
Price-to-Operating-Cash-Flow | 5.71 | |||||
EV-to-EBIT | -12.13 | |||||
EV-to-Forward-EBIT | -30.86 | |||||
EV-to-EBITDA | 14.7 | |||||
EV-to-Forward-EBITDA | 9.27 | |||||
EV-to-Revenue | 0.96 | |||||
EV-to-Forward-Revenue | 0.94 | |||||
EV-to-FCF | 12.62 | |||||
Price-to-Projected-FCF | 0.84 | |||||
Earnings Yield (Greenblatt) % | -8.24 | |||||
FCF Yield % | 9.85 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return %
Total Annual Return %
Teladoc Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil R$) | 12,881.353 | ||
EPS (TTM) (R$) | -6.943 | ||
Beta | 0.78 | ||
Volatility % | 48.75 | ||
14-Day RSI | 25.36 | ||
14-Day ATR (R$) | 0.081086 | ||
20-Day SMA (R$) | 2.248 | ||
12-1 Month Momentum % | -40.34 | ||
52-Week Range (R$) | 2.04 - 4.78 | ||
Shares Outstanding (Mil) | 169.59 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Teladoc Health Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Teladoc Health Inc Stock Events
Event | Date | Price(R$) | ||
---|---|---|---|---|
No Event Data |
Teladoc Health Inc Frequently Asked Questions
What is Teladoc Health Inc(BSP:T2DH34)'s stock price today?
When is next earnings date of Teladoc Health Inc(BSP:T2DH34)?
Does Teladoc Health Inc(BSP:T2DH34) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |